Cardinal Health is a top idea for 2014, says RW Baird Baird said Cardinal Health is a top idea for 2014 as it previews its Q2 earnings. The firm expects continued momentum in its product portfolio, its uptrend in earnings to continue, and likes its capital deployment flexibility. Shares are Outperform rated with an $80 price target.
Cardinal Health raises FY16 non-GAAP EPS to $4.85-$5.05 from $4.28-$4.38 FY16 EPS consensus of $4.37. The updated guidance is due to strong FY15 performance momentum it carried into FY16. It expects financial performance to be weighted towards 2H16.